This study aimed to establish whether the high-level MYCN-amplified, RB1-proficient (MYCNARB1PRO) retinoblastoma present in this cohort displays unique molecular features that discriminate them from the rest of the retinoblastoma genomic subtypes. This evidence concerns the gene RB1 and retinoblastoma.